Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMC Cancer|April 12, 2019
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysisShing Fung Lee, Ting Ying Ng, Devon Spika
American Journal of Clinical Oncology|December 1, 2018
The Value of Prognostic Nutritional Index in Follicular LymphomaShing Fung Lee, Ting Ying Ng, Frank Chi Sing Wong
Leukemia Research Reports|March 24, 2017
Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysisShing Fung Lee, Ting Ying Ng, Frank Chi Sing Wong, et al.
American Journal of Clinical Oncology|March 7, 2017
The Role of Radiotherapy in Early-stage Primary Diffuse Large B-Cell Lymphoma of the Waldeyer Ring: A Retrospective Cohort StudyShing Fung Lee, Ting Ying Ng, Frank Chi Sing Wong, et al.
Expert Opinion on Investigational Drugs|February 12, 2013
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II - III invasive breast cancer: the OOTR-N001 studyLouis W C Chow, Stewart Y Tung, Ting-Ying Ng, et al.
Head & Neck|March 14, 2002
High dose rate brachytherapy for early stage oral tongue cancerTo-Wai Leung, Victy Yee-Wa Wong, Kin-Hung Kwan, et al.
Archives of Medical Science : AMS|August 7, 2014
Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong ChineseMan Fai Law, Ting Ying Ng, Hay Nun Chan, et al.
Head & Neck|May 10, 2005
Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patternsTo-Wai Leung, Stewart Yuk Tung, Wing-Kin Sze, et al.
Breast Cancer Research and Treatment|April 16, 2021
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE studyChiun-Sheng Huang, Youngsen Yang, Ava Kwong, et al.
Breast Cancer Research : BCR|April 13, 2017
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1Masakazu Toi, Zhimin Shao, Sara Hurvitz, et al.
Pageof 2